Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma.

Yoshikawa Y, Sato A, Tsujimura T, Emi M, Morinaga T, Fukuoka K, Yamada S, Murakami A, Kondo N, Matsumoto S, Okumura Y, Tanaka F, Hasegawa S, Nakano T, Hashimoto-Tamaoki T.

Cancer Sci. 2012 May;103(5):868-74. doi: 10.1111/j.1349-7006.2012.02223.x. Epub 2012 Feb 21.

2.

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.

Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, Bercich L, Bugatti M, Rossi G, Murer B, Barbareschi M, Giuliani S, Cavazza A, Marchetti G, Vermi W, Facchetti F.

Mod Pathol. 2015 Aug;28(8):1043-57. doi: 10.1038/modpathol.2015.65. Epub 2015 May 29.

3.

Tumours associated with BAP1 mutations.

Murali R, Wiesner T, Scolyer RA.

Pathology. 2013 Feb;45(2):116-26. doi: 10.1097/PAT.0b013e32835d0efb. Review.

PMID:
23277170
4.

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.

Alakus H, Yost SE, Woo B, French R, Lin GY, Jepsen K, Frazer KA, Lowy AM, Harismendy O.

J Transl Med. 2015 Apr 16;13:122. doi: 10.1186/s12967-015-0485-1.

5.

Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.

Wu D, Hiroshima K, Yusa T, Ozaki D, Koh E, Sekine Y, Matsumoto S, Nabeshima K, Sato A, Tsujimura T, Yamakawa H, Tada Y, Shimada H, Tagawa M.

Ann Diagn Pathol. 2017 Feb;26:31-37. doi: 10.1016/j.anndiagpath.2016.10.010. Epub 2016 Oct 22.

PMID:
28038708
6.

Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level.

Emi M, Yoshikawa Y, Sato C, Sato A, Sato H, Kato T, Tsujimura T, Hasegawa S, Nakano T, Hashimoto-Tamaoki T.

J Hum Genet. 2015 Oct;60(10):647-9. doi: 10.1038/jhg.2015.91. Epub 2015 Aug 6.

PMID:
26246155
7.

Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells.

Hakiri S, Osada H, Ishiguro F, Murakami H, Murakami-Tonami Y, Yokoi K, Sekido Y.

Cancer Sci. 2015 Aug;106(8):990-9. doi: 10.1111/cas.12698. Epub 2015 Jun 25.

8.

Loss of expression of BAP1 predicts longer survival in mesothelioma.

Farzin M, Toon CW, Clarkson A, Sioson L, Watson N, Andrici J, Gill AJ.

Pathology. 2015 Jun;47(4):302-7. doi: 10.1097/PAT.0000000000000250.

PMID:
25938359
9.

Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.

Togo Y, Yoshikawa Y, Suzuki T, Nakano Y, Kanematsu A, Zozumi M, Nojima M, Hirota S, Yamamoto S, Hashimoto-Tamaoki T.

Int J Oncol. 2016 Apr;48(4):1571-80. doi: 10.3892/ijo.2016.3395. Epub 2016 Feb 17.

PMID:
26891804
10.

Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.

Kalra N, Zhang J, Thomas A, Xi L, Cheung M, Talarchek J, Burkett S, Tsokos MG, Chen Y, Raffeld M, Miettinen M, Pastan I, Testa JR, Hassan R.

BMC Cancer. 2015 May 8;15:376. doi: 10.1186/s12885-015-1362-2.

11.

Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.

Xu J, Kadariya Y, Cheung M, Pei J, Talarchek J, Sementino E, Tan Y, Menges CW, Cai KQ, Litwin S, Peng H, Karar J, Rauscher FJ, Testa JR.

Cancer Res. 2014 Aug 15;74(16):4388-97. doi: 10.1158/0008-5472.CAN-14-1328. Epub 2014 Jun 13.

12.

Germline BAP1 mutations predispose to malignant mesothelioma.

Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M.

Nat Genet. 2011 Aug 28;43(10):1022-5. doi: 10.1038/ng.912.

13.

BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.

Morrison A, Chekaluk Y, Bacares R, Ladanyi M, Zhang L.

PLoS One. 2015 Apr 1;10(4):e0119224. doi: 10.1371/journal.pone.0119224. eCollection 2015.

14.

An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.

Cheung M, Kadariya Y, Pei J, Talarchek J, Facciolo F, Visca P, Righi L, Cozzi I, Testa JR, Ascoli V.

Cancer Genet. 2015 Oct;208(10):502-7. doi: 10.1016/j.cancergen.2015.07.004. Epub 2015 Jul 30.

15.

BAP1 protein is a progression factor in malignant pleural mesothelioma.

Arzt L, Quehenberger F, Halbwedl I, Mairinger T, Popper HH.

Pathol Oncol Res. 2014 Jan;20(1):145-51. doi: 10.1007/s12253-013-9677-2. Epub 2013 Aug 22.

PMID:
23963927
16.

Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.

Rusch A, Ziltener G, Nackaerts K, Weder W, Stahel RA, Felley-Bosco E.

Lung Cancer. 2015 Jan;87(1):77-9. doi: 10.1016/j.lungcan.2014.10.017. Epub 2014 Nov 6.

PMID:
25468148
17.

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.

Zauderer MG, Bott M, McMillan R, Sima CS, Rusch V, Krug LM, Ladanyi M.

J Thorac Oncol. 2013 Nov;8(11):1430-3. doi: 10.1097/JTO.0b013e31829e7ef9.

18.

Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.

Yoshikawa Y, Sato A, Tsujimura T, Morinaga T, Fukuoka K, Yamada S, Murakami A, Kondo N, Matsumoto S, Okumura Y, Tanaka F, Hasegawa S, Hashimoto-Tamaoki T, Nakano T.

Int J Oncol. 2011 Dec;39(6):1365-74. doi: 10.3892/ijo.2011.1158. Epub 2011 Aug 12.

PMID:
21842119
19.

High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.

Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, Yang H, Carbone M.

J Thorac Oncol. 2015 Apr;10(4):565-76. doi: 10.1097/JTO.0000000000000471.

20.

Mesothelioma families without inheritance of a BAP1 predisposing mutation.

Ascoli V, Cozzi I, Vatrano S, Izzo S, Giorcelli J, Romeo E, Carnovale-Scalzo C, Grillo LR, Facciolo F, Visca P, Papotti M, Righi L.

Cancer Genet. 2016 Sep;209(9):381-387. doi: 10.1016/j.cancergen.2016.07.002. Epub 2016 Jul 18.

Supplemental Content

Support Center